Science 37

03/27/2026

Pediatric clinical research is entering a new era — one where specialized care and broader access are coming together to better support young patients and their families. Expanding access to trials can help drive innovation while making participation more inclusive and patient-centered.

💜 Explore how pediatric clinical research is evolving and what this shift means for the future of care.
👉 Read the full article: https://www.science37.com/blog/specialized-care-universal-access-a-new-era-for-pediatric-clinical-research/

Author: BouaSy Huneycutt, MD, Medical Director, Pediatric Medicine For any parent, a child’s illness is a […]

03/25/2026

Lennox-Gastaut Syndrome (LGS) affects more than just seizures — it can also impact cognitive development and behavior, creating additional challenges for patients and caregivers. Understanding these effects is key to providing more comprehensive, supportive care.

💜 Learn how LGS impacts cognition and behavior and explore ways to better manage these challenges.
👉 Read the full article: https://studies.science37.com/beyond-the-seizures-managing-the-cognitive-and-behavioral-impact-of-lennox-gastaut-syndrome/

Explore the hidden cognitive and behavioral challenges of LGS. Learn how at-home LGS clinical trials with Science 37 focus on treating the whole person.

03/19/2026

Science 37 announced the formal launch of its dedicated 𝗣𝗲𝗱𝗶𝗮𝘁𝗿𝗶𝗰𝘀 𝗗𝗲𝗽𝗮𝗿𝘁𝗺𝗲𝗻𝘁, reinforcing the company’s commitment to advancing pediatric research by reducing the logistical and emotional burden placed on families.

Pediatric clinical trials have historically struggled with slow enrollment, high dropout rates, and limited geographical reach due to the challenges families face traveling to traditional research sites.

Science 37’s pediatric model brings specialized clinical trial activities directly into the home or school, enabling children to participate in research without disrupting school, family routines, or caregiver responsibilities.

Central to the department’s success is an in-house team trained in age-appropriate, family-centered clinical care, featuring:

• 𝗗𝗲𝗱𝗶𝗰𝗮𝘁𝗲𝗱 𝗜𝗻𝘃𝗲𝘀𝘁𝗶𝗴𝗮𝘁𝗼𝗿𝘀: Broadly-licensed doctors specializing in pediatric health and safety.

• 𝗣𝗲𝗱𝗶𝗮𝘁𝗿𝗶𝗰 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵-𝗚𝗿𝗮𝗱𝗲 𝗡𝘂𝗿𝘀𝗲𝘀: A nationwide network of pediatric-trained Research-Grade Nurses with experience in pediatric clinical settings and home-based care.

• 𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗖𝗼𝗼𝗿𝗱𝗶𝗻𝗮𝘁𝗼𝗿𝘀 𝗮𝗻𝗱 𝗦𝗶𝘁𝗲 𝗢𝗽𝗲𝗿𝗮𝘁𝗶𝗼𝗻𝘀 𝗦𝗽𝗲𝗰𝗶𝗮𝗹𝗶𝘀𝘁𝘀: Trained specifically to support parents and caregivers throughout the study.

"As an industry, we have asked families to fit research into their lives, rather than designing research to fit into childhood," said Dr. Debra Weinstein, Chief Medical Officer at Science 37. "Our focus is on removing the barriers that prevent children from accessing potentially life-changing research, while maintaining the highest standards of safety, clinical rigor, and pediatric expertise."

🧸 Read the full announcement: https://lnkd.in/eQG9zmEp

03/18/2026

🧸 We’ve been working on something special for our youngest participants.

For too long, the industry has asked families to fit research into their lives. At Science 37, we’re doing the opposite.

We’re fitting clinical research into families' lives—not asking them to fit into ours. No disrupting school, work, or daily routines.

Stay tuned tomorrow for an exciting announcement...

03/17/2026

Care for Dravet Syndrome is evolving, with new research opening doors to better treatments, improved support, and more personalized approaches for patients and families. As science advances, so does the hope for better outcomes in rare epilepsy care.

💜 Explore the latest breakthroughs in Dravet Syndrome research and what they mean for the future of care.
👉 Read the full article: https://studies.science37.com/the-evolution-of-dravet-syndrome-care-new-frontiers-in-rare-epilepsy-research/

Discover how precision medicine and at-home clinical trials with Science 37 are transforming Dravet syndrome care for children with the SCN1A mutation.

03/16/2026

GLP-1 treatments are evolving — from injectable pens to new oral weight-loss pills. Which option could be right for patients?

03/11/2026

🌴🩺 The Science 37 team had a great time in Orlando at Modern Nurse Fest!

🎤 Session Highlight:
Translating Science Into Care: The Role of Clinical Research Nurses

Brooke Silva and Liz Jones shared insights on how nurses are helping shape the future of clinical research — bringing trials closer to patients, expanding access, and improving the overall patient experience.

A big thank you to everyone who joined the session and stopped by to connect. We loved meeting so many passionate nurses and healthcare professionals! 💙

03/09/2026

📍 𝗢𝘂𝗿 𝘁𝗲𝗮𝗺 𝗶𝘀 𝗵𝗲𝗮𝗱𝗶𝗻𝗴 𝘁𝗼 hashtag #𝗢𝗖𝗧𝗦𝗼𝘂𝘁𝗵𝗲𝗮𝘀𝘁 𝗶𝗻 𝗥𝗧𝗣!

Michael Biron, Allan Badulis, and Michael Wright will be on-site, sharing how our 𝗙𝗗𝗔-𝗶𝗻𝘀𝗽𝗲𝗰𝘁𝗲𝗱 𝗗𝗶𝗿𝗲𝗰𝘁-𝘁𝗼-𝗣𝗮𝘁𝗶𝗲𝗻𝘁 𝗦𝗶𝘁𝗲 is helping study sponsors reach more patients across the US—all from the comfort of their homes. 🏠

Stop by Booth #5 to connect with us!

Or, schedule a meeting here: https://www.science37.com/events/

hashtag hashtag hashtag

03/06/2026

GLP-1 treatments are evolving quickly — from traditional injections to new oral options that could change how patients manage their care. Understanding these differences can help patients and providers navigate the next wave of treatment options.

👉 Learn more about the changing landscape of GLP-1 treatments:
https://studies.science37.com/pills-vs-pens-the-changing-landscape-of-glp-1-treatments/

If you have followed health news recently, you have undoubtedly heard about the "weight loss revolution" driven by medications like Ozempic, Wegovy, and Zepbound. These drugs, known as GLP-1 receptor agonists, have changed the game for type 2 diabetes management and long term weight management. Howe...

03/04/2026

Dravet Syndrome can come with symptoms that many people don’t immediately recognize. Raising awareness about these lesser-known signs can help families and caregivers better understand the condition.

02/26/2026

𝗦𝗖𝗢𝗣𝗘 𝟮𝟬𝟮𝟲 𝗶𝗻 𝗢𝗿𝗹𝗮𝗻𝗱𝗼 🌴 — 𝗼𝘂𝗿 𝗯𝗲𝘀𝘁 𝘆𝗲𝘁.

From nonstop booth traffic to meaningful conversations about the future of clinical trials, the energy this year was unmatched. We loved seeing so much interest in how Science 37 𝗼𝗽𝗲𝗿𝗮𝘁𝗲𝘀 𝗮𝘀 𝗮 𝗰𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗿𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝘀𝗶𝘁𝗲—𝗯𝗿𝗶𝗻𝗴𝗶𝗻𝗴 𝘁𝗿𝗶𝗮𝗹𝘀 𝗱𝗶𝗿𝗲𝗰𝘁𝗹𝘆 𝘁𝗼 𝗽𝗮𝘁𝗶𝗲𝗻𝘁𝘀.

🏠 𝗔𝘁 𝗼𝘂𝗿 𝗯𝗼𝗼𝘁𝗵
Our “living room” was buzzing all week as attendees stepped in for our first-ever live, at-home demos—getting a firsthand look at how our team delivers FDA-compliant, direct-to-patient trials.

🐢 𝗧𝘂𝗿𝘁𝗹𝗲𝘀 𝗳𝗼𝗿 𝗴𝗼𝗼𝗱
Together, we supported children’s hospitals advancing clinical research—thank you to everyone who joined us in giving back.

🏆 𝗔𝘄𝗮𝗿𝗱𝘀 𝗿𝗲𝗰𝗼𝗴𝗻𝗶𝘁𝗶𝗼𝗻
We’re proud to have been named a finalist for both the 𝗦𝗶𝘁𝗲 𝗜𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻 𝗔𝘄𝗮𝗿𝗱 and the 𝗣𝗮𝗿𝘁𝗶𝗰𝗶𝗽𝗮𝗻𝘁 𝗘𝗻𝗴𝗮𝗴𝗲𝗺𝗲𝗻𝘁 𝗔𝘄𝗮𝗿𝗱.

🎤 𝗣𝗮𝗻𝗲𝗹 𝗵𝗶𝗴𝗵𝗹𝗶𝗴𝗵𝘁𝘀
Huge thanks to Debra Weinstein, Arthur Van Leerberghe, Maria I. Florez, John Reites, and Michelle Giovannucci, RPh, for sharing insights on embedding flexibility early in trial design.

💚 𝗧𝗵𝗮𝗻𝗸 𝘆𝗼𝘂
To everyone who stopped by, joined a demo, or sparked a conversation...thank you for making SCOPE 2026 one to remember.

Missed us onsite or want to keep the conversation going? We’d love to connect: https://lnkd.in/gpxk9gN8

SCOPE 365

02/24/2026

For individuals living with Lennox-Gastaut Syndrome (LGS), growing up brings new challenges — especially when it comes to transitioning from pediatric to adult care. Planning ahead and understanding what to expect can make this shift smoother for patients and caregivers alike.

💜 Learn how to navigate the transition to adult care when LGS grows up and explore resources designed to support families through every stage.
👉 https://studies.science37.com/when-lgs-grows-up-navigating-the-transition-to-adult-care/?&

When a child is diagnosed with Lennox-Gastaut Syndrome (LGS), the focus is almost exclusively on the "now." Parents are consumed by managing daily seizures, navigating developmental delays, and fighting for the best pediatric care. But children with LGS do grow up. Thanks to advances in medical care...